Abstract
Campylobacter jejuni (C. jejuni) enteritis is generally self-limited, but occasionally triggers extraintestinal associated sequelae. We examined whether cytopenia is associated with C. jejuni enteritis. A retrospective case-controlled study of C. jejuni and Escherichia coli (E. coli) enteritis patients, who were microbiologically confirmed in our hospital from February 2006 to October 2017, was conducted. Leukocytopenia and thrombocytopenia were defined as statuses less than 4.0 × 109/L and 130 × 109/L during their clinical courses, respectively. Clinical and microbiological data were collected. Risk factors for cytopenia were assessed by a multivariate analysis. The two eligible cohorts comprised 138 C. jejuni (71 inpatients) and 35 E. coli (34 inpatients) enteritis patients. The prevalence of leukocytopenia or thrombocytopenia in the C. jejuni patients was 7.9% (11/138) and 5.0% (7/138), and that in the E. coli patients was 0% (0/35) and 5.7% (2/35), respectively. Leukocytopenia was more prevalent in the C. jejuni enteritis inpatients than in the E. coli inpatients, but there were no significant differences in thrombocytopenia in both cohorts. The mean minimum leukocyte values were determined after an average of three admission days in the C. jejuni inpatients. The elevations of C-reactive protein and creatinine were risk factors for thrombocytopenia and leukocytopenia, respectively. Hemophagocytosis was detected in a C. jejuni enteritis patient with cytopenia. The present study suggested that leukocytopenia is a possible extraintestinal sequela in some C. jejuni enteritis patients. Hemophagocytosis should be considered as one of underlying mechanisms when cytopenia is found in these patients.
Availability of Data and Materials
All data generated or analyzed during this study are included within the article.
Abbreviations
- C. jejuni :
-
Campylobacter jejuni
- E. coli :
-
Escherichia coli
- GBS:
-
Guillain-Barre syndrome
- WBC:
-
white blood cell
- Cre:
-
creatinine
- LDH:
-
lactate dehydrogenase
- ALT:
-
alanine aminotransferase
- CRP:
-
C-reactive protein
- EB:
-
Epstein-Barr
- Ig:
-
immunoglobulin
- PAIgG:
-
platelet-associated IgG
- HUS:
-
hemolytic uremic syndrome
References
Koga M, Yuki N, Tsukada Y, Hirata K, Matsumoto Y. CDR3 spectratyping analysis of the T cell receptor repertoire in Guillain-Barre and Fisher syndromes. J Neuroimmunol. 2003;141(1–2):112–7.
Halpin AL, Gu W, Wise ME, Sejvar JJ, Hoekstra RM, Mahon BE. Post-Campylobacter Guillain Barre syndrome in the USA: secondary analysis of surveillance data collected during the 2009-2010 novel Influenza A (H1N1) vaccination campaign. Epidemiol Infect. 2018;146(13):1740–5.
Brooks PT, Brakel KA, Bell JA, Bejcek CE, Gilpin T, Brudvig JM, et al. Transplanted human fecal microbiota enhanced Guillain Barre syndrome autoantibody responses after Campylobacter jejuni infection in C57BL/6 mice. Microbiome. 2017;5(1):92.
Heimesaat MM, Haag LM, Fischer A, Otto B, Kuhl AA, Gobel UB, et al. Survey of extra-intestinal immune responses in asymptomatic long-term Campylobacter jejuni-infected mice. Eur J Microbiol Immunol (Bp). 2013;3(3):174–82.
Zautner AE, Johann C, Strubel A, Busse C, Tareen AM, Masanta WO, et al. Seroprevalence of campylobacteriosis and relevant post-infectious sequelae. Eur J Clin Microbiol Infect Dis. 2014;33(6):1019–27.
Rouphael NG, Talati NJ, Vaughan C, Cunningham K, Moreira R, Gould C. Infections associated with haemophagocytic syndrome. Lancet Infect Dis. 2007;7(12):814–22.
Pacanowski J, Lalande V, Lacombe K, Boudraa C, Lesprit P, Legrand P, et al. Campylobacter bacteremia: clinical features and factors associated with fatal outcome. Clin Infect Dis. 2008;47(6):790–6.
Polak P, Vrba M, Bortlicek Z, Jurankova J, Freibergerova M, Husa P, et al. Campylobacteriosis at the Department of Infectious Diseases of the University Hospital Brno in 2011-2013: a retrospective study. Epidemiol Mikrobiol Imunol. 2015;64(3):153–9.
Schattner A. Campylobacter jejuni and cytopenias. Am J Med. 2013;126(11):1020–1.
Kanda Y. Statistical analysis using freely-available “EZR (Easy R)” software. Rinsho Ketsueki. 2015;56(10):2258–66.
Rai B, Ray R. Campylobacter jejuni gastroenteritis complicated by pancytopenia. Indian Pediatr. 2014;51(6):505.
Wong KF, Chan JK. Reactive hemophagocytic syndrome--a clinicopathologic study of 40 patients in an Oriental population. Am J Med. 1992;93(2):177–80.
Haag LM, Fischer A, Otto B, Grundmann U, Kuhl AA, Gobel UB, et al. Campylobacter jejuni infection of infant mice: acute enterocolitis is followed by asymptomatic intestinal and extra-intestinal immune responses. Eur J Microbiol Immunol (Bp). 2012;2(1):2–11.
Anstead G, Jorgensen J, Craig F, Blaser M, Patterson T. Thermophilic multidrug-resistant Campylobacter fetus infection with hypersplenism and histiocytic phagocytosis in a patient with acquired immunodeficiency syndrome. Clin Infect Dis. 2001;32(2):295–6.
Arora S, Gupta N, Kumar A, Kaur IR. Salmonella enteritidis from a case of fever with thrombocytopenia. Asian Pac J Trop Med. 2011;4(4):328–9.
Nagano M, Kimura N, Ishii E, Yoshida N, Yoshida T, Sako M, et al. Clonal expansion of alphabeta-T lymphocytes with inverted Jbeta1 bias in familial hemophagocytic lymphohistiocytosis. Blood. 1999;94(7):2374–82.
Wada T, Sakakibara Y, Nishimura R, Toma T, Ueno Y, Horita S, et al. Down-regulation of CD5 expression on activated CD8+ T cells in familial hemophagocytic lymphohistiocytosis with perforin gene mutations. Hum Immunol. 2013;74(12):1579–85.
Lecuit M, Abachin E, Martin A, Poyart C, Pochart P, Suarez F, et al. Immunoproliferative small intestinal disease associated with Campylobacter jejuni. N Engl J Med. 2004;350(3):239–48.
Van Rhijn I, Van den Berg LH, Ang CW, Admiraal J, Logtenberg T. Expansion of human gammadelta T cells after in vitro stimulation with Campylobacter jejuni. Int Immunol. 2003;15(3):373–82.
Acknowledgments
We thank Harumi Matsumoto for her technical support.
Funding
This work was supported by a grant-in-aid for scientific research, KAKENHI grant number 16K10376 (K. Tajima), from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.
Author information
Authors and Affiliations
Contributions
KT and SO conceived the study and designed its methodological aspects. HK treated the patient. DA performed microbiological culture. The manuscript was prepared by SO and KT. All authors approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that there are no conflicts of interest.
Ethics Approval and Consent to Participate
This study was approved by the Ethics Committee of Yamagata Prefectural Central Hospital.
Consent for Publication
Consent for the publication of this case and any additional related information was taken from the patient involved in this study.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article is part of the Topical Collection on Medicine
Electronic Supplementary Material
ESM 1
(PDF 25748 kb)
Rights and permissions
About this article
Cite this article
Okuyama, S., Kumagai, H., Akaneya, D. et al. Cytopenia in Campylobacter jejuni Enteritis Patients. SN Compr. Clin. Med. 1, 677–681 (2019). https://doi.org/10.1007/s42399-019-00109-x
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s42399-019-00109-x